Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site’s displayed software revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T14:30:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.5%
    Check dated 2026-10-25T13:35:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:07:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T13:43:54.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added to the study history, replacing the previous v3.6.6. This indicates an update to the record in the history log.
    Difference
    0.1%
    Check dated 2026-09-20T19:46:33.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The revision history shows a new entry for Revision: v3.6.6 and a removal of Revision: v3.6.5, indicating an update to the page's versioned documentation.
    Difference
    0.1%
    Check dated 2026-08-30T06:37:04.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.